SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-024060
Filing Date
2018-04-16
Accepted
2018-04-16 07:00:56
Documents
3
Period of Report
2018-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-10108_18k.htm 8-K 26748
2 EX-99.1 a18-10108_1ex99d1.htm EX-99.1 12061
3 GRAPHIC g101081mmi001.jpg GRAPHIC 5185
  Complete submission text file 0001104659-18-024060.txt   47489
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 18755496
SIC: 2834 Pharmaceutical Preparations